AI assistant
Sending…
Vitrolife — Major Shareholding Notification 2009
Apr 9, 2009
2989_iss_2009-04-09_6df89b34-ec10-4c4e-a426-099d2e0f9cd5.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Vitrolife AB
Holder
SEB Investment Management AB
Instrument
| Instrument | Aktier SE0000816043 |
|---|---|
| Before the transaction | |
| Shares | 1,058,858 |
| Voting rights | 1,058,858 |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 08/04/2009 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 987,858 |
| Directly held voting rights | 987,858 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 4.99 % |
| Directly held voting rights | 4.99 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | ||
| Instruments - FITA Ch. 4, section 2, first |
paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
-
Physically settled
-
Cash settled
Total
Notes (other relevant informations according to law) För fonds räkning
Published
09/04/2009 13:16
Contact
Name Johan Lycke Phone 08-522 296 41 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Vitrolife
Board/Management Information
2026
May 22
Board/Management Information
2026
May 22
AGM Information
2026
May 5
AGM Information
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Board/Management Information
2026
Apr 1
Board/Management Information
2026
Apr 1
Annual Report
2026
Mar 26
Annual Report
2026
Mar 26